Tsuneo Imanaka Selected Research

Tsuneo Imanaka Research Topics

Disease

16	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022 - 09/2002
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 06/2009
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 09/2012
2	Pathologic Processes 01/2018 - 09/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2005 - 12/2002
1	Disease Progression 01/2021
1	Homocystinuria 01/2021
1	Methylmalonic acidemia 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Coma (Comas) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Glucose Intolerance 09/2015
1	Obesity 09/2015
1	Body Weight (Weight, Body) 09/2015
1	Insulin Resistance 09/2015
1	Zellweger Syndrome (Zellweger's Syndrome) 12/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2012
1	Achalasia Addisonianism Alacrimia syndrome 06/2009
1	Rupture 10/2008
1	Coronary Disease (Coronary Heart Disease) 10/2008
1	Atherosclerosis 10/2008
1	Atherosclerotic Plaque (Atheroma) 10/2008
1	Hepatocellular Carcinoma (Hepatoma) 04/2002

Drug/Important Bio-Agent (IBA)

10	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2005
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
3	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 01/2019 - 06/2007
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022 - 01/2021
2	Acyl Coenzyme A (Acyl CoA)IBA 01/2021 - 09/2015
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018 - 09/2012
2	LipidsIBA 01/2018 - 12/2013
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 12/2013
2	AntithrombinsIBA 03/2005 - 12/2002
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2005 - 12/2002
2	DisulfidesIBA 03/2005 - 12/2002
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	MicronutrientsIBA 01/2021
1	Lorenzo's oilIBA 01/2018
1	lignoceric acid (tetracosanoic acid)IBA 01/2016
1	pyreneIBA 01/2016
1	Diacylglycerol O-AcyltransferaseIBA 09/2015
1	Dietary Fats (Dietary Fat)IBA 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Insulin (Novolin)FDA Link 09/2015
1	(5'- (4- amino- 7,7- dimethyl- 2- trifluoromethyl- 7H- pyrimido(4,5- b)(1,4)oxazin- 6- yl)- 2',3'- dihydrospiro(cyclohexane- 1,1'- inden)- 4- yl)acetic acidIBA 09/2015
1	ethyl 2- (5- (4- chlorophenyl)pentyl)oxiran- 2- carboxylate (POCA)IBA 01/2012
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2012
1	Ethylene Oxide (Oxirane)IBA 01/2012
1	Aspartic Acid (Aspartate)FDA Link 06/2009
1	Tryptophan (L-Tryptophan)FDA Link 06/2009
1	oxidized low density lipoproteinIBA 10/2008
1	AntibodiesIBA 10/2008
1	Monoclonal AntibodiesIBA 10/2008
1	EpitopesIBA 10/2008
1	CholesterolIBA 10/2008
1	Cholesterol Esters (Cholesteryl Esters)IBA 10/2008
1	Lipoproteins (Lipoprotein)IBA 10/2008
1	Proteasome InhibitorsIBA 06/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2007
1	FlavonoidsIBA 01/2005
1	baicalein 5,6,7-trimethyl etherIBA 01/2005
1	baicaleinIBA 01/2005
1	microsomal triglyceride transfer proteinIBA 04/2002
1	iodixanol (Visipaque)FDA Link 04/2002

Therapy/Procedure

2	Therapeutics 05/2011 - 01/2005
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021